InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc. (INM) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · INM · as of Jun 9, 2026
Activity summary
Buy transactions
3
P-Purchase only
Sell transactions
0
12 Months
Buy/Sell ratio
∞
Buy/Sell (by trades)
Overall sentiment
InMed Pharmaceuticals Inc. insiders have been net buyers of shares over the past 12 Months, which may signal confidence in the company's outlook.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 9, 2026
INM insider buying and selling by quarter
INM insider selling · INM insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 9, 2026
Recent insider transactions
INM executive sell shares · INM board member insider trading · INM insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Jul 31, 2024 | MANCINI ALEXANDRA DIANE JANET other: Consultant | Sale | 240 | $42 | Form 4 |
| Feb 21, 2024 | HULL ANDREW Director | Purchase | 37,500 | $15K | Form 4 |
| Feb 20, 2024 | ADAMS ERIC A President & CEO · Director | Purchase | 41,600 | $15K | Form 4 |
| Apr 14, 2022 | ADAMS ERIC A President & CEO | Purchase | 14,160 | $13K | Form 4 |
| Apr 13, 2022 | ADAMS ERIC A President & CEO | Purchase | 8,560 | $7K | Form 4 |
MANCINI ALEXANDRA DIANE JANET
other: Consultant
Date
Jul 31
Shares
240
Price
$0.18
Value
$42
ADAMS ERIC A
President & CEO · Director
Date
Feb 20
Shares
41,600
Price
$0.36
Value
$15K
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About INM insider trading
INM insider trades
InMed Pharmaceuticals Inc. (INM) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including INM. Over the past 12 months, 0 insiders have filed transactions with the SEC. INM insiders have been primarily buying, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For InMed Pharmaceuticals Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
INM insider trading · 5 questionsThe insiders of InMed Pharmaceuticals Inc. (INM) include executives and directors such as INM, among others. Over the past 12 months, 0 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026